Programs and Projects
Ovarian Cancer Prevention Clinical Trials
Ongoing Phase II Prevention Trials Monitored by the Breast and Gynecologic Cancer Research Group (BGCRG)
Contracts
| Principal Investigator |
Institution |
Title of Award |
Chemopreventive Agent |
BGCRG Medical Monitor |
| Robert Park, M.D. |
Gynecologic Oncology Group |
Fenretinide as Chemoprevention in Ovarian Carcinoma |
4-HPR |
Karen Johnson, M.D. |
|
Cooperative Agreements
| Principal Investigator |
Institution |
Title of Award |
Chemopreventive Agent |
BGCRG Medical Monitor |
| Molly Brewer, M.D. |
University of Arizona |
A Multicenter Randomized Double-Blinded Trial for Chemoprevention of Ovarian Cancer: Modulation of Biomarkers and Spectral Properties using Contrast Enhanced Ultrasound In High-risk Women using Fenretinide (4-HPR) |
4-HPR
Placebo |
Karen Johnson, M.D. |
|
This page was last updated on June 6, 2006.
